1. Aetio-pathogenesis and the management of spontaneous liver bleeding in the West: a 16-year single-centre experience.
- Author
-
Battula N, Tsapralis D, Takhar A, Coldham C, Mayer D, Isaac J, Muiesan P, Sutcliffe RP, Marudanayagam R, Mirza DF, and Bramhall SR
- Subjects
- Abdominal Pain etiology, Adenoma, Liver Cell complications, Adenoma, Liver Cell therapy, Adult, Aged, Carcinoma, Hepatocellular complications, Carcinoma, Hepatocellular therapy, Cysts complications, Cysts therapy, Embolization, Therapeutic, England, Female, HELLP Syndrome therapy, Hemorrhage diagnosis, Hemorrhage mortality, Hemostatic Techniques, Hepatectomy, Hospital Mortality, Humans, Liver Diseases diagnosis, Liver Diseases mortality, Liver Neoplasms complications, Liver Neoplasms therapy, Male, Middle Aged, Predictive Value of Tests, Pregnancy, Retrospective Studies, Risk Assessment, Risk Factors, Survival Analysis, Time Factors, Treatment Outcome, Young Adult, Hemorrhage etiology, Hemorrhage therapy, Liver Diseases etiology, Liver Diseases therapy
- Abstract
Background: Spontaneous liver bleeding (SLB) is a rare but potentially fatal complication. In contrast to the East, various benign pathologies are the source of SLB in the West. An accurate diagnosis and a timely implementation of appropriate treatment are crucial in the management of these patients. The present study presents a large Western experience of SLB from a specialist liver centre., Methods: A retrospective analysis of patients presented with SLB between January 1995 and January 2011., Results: Sixty-seven patients had SLB, 44 (66%) were female and the median age at presentation was 47 years. Abrupt onset upper abdominal pain was the presenting symptom in 65 (97%) patients. The aetiology for SLB was hepatic adenoma in 27 (40%), hepatocellular carcinoma (HCC) in 17 (25%) and various other liver pathologies in the rest. Emergency treatment included a conservative approach in 42 (64%), DSA and embolization in 6 (9%), a laparotomy and packing in 6 (9%) and a liver resection in 11 (16%) patients. Eleven (16%) patients had further planned treatments. Seven (10%) died during the same admission but the mortality was highest in patients with HELLP syndrome. At a median follow-up of 54 months all patients with benign disease are alive. The 1-, 3- and 5-year survival of patients with HCC was 59%, 35% and 17%, respectively., Conclusion: SLB is a life-threatening complication of various underlying conditions and may represent their first manifestation. The management should include initial haemostasis followed by appropriate staging investigations to provide a definitive treatment for each individual patient., (© 2012 International Hepato-Pancreato-Biliary Association.)
- Published
- 2012
- Full Text
- View/download PDF